Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TIL

Instill Bio (TIL)

Instill Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TIL
DateTimeSourceHeadlineSymbolCompany
22/03/202408:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
15/02/202408:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/02/202409:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
18/01/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
17/01/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
17/01/202400:00GlobeNewswire Inc.Instil Bio Announces Strategic UpdateNASDAQ:TILInstill Bio Inc
11/01/202412:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
11/01/202411:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
09/12/202309:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
06/12/202309:00GlobeNewswire Inc.Instil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNASDAQ:TILInstill Bio Inc
27/11/202323:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/11/202309:27Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:TILInstill Bio Inc
14/11/202309:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
14/11/202309:00GlobeNewswire Inc.Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
14/11/202309:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
06/11/202323:00GlobeNewswire Inc.Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNASDAQ:TILInstill Bio Inc
14/08/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
14/08/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/08/202321:00GlobeNewswire Inc.Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
27/06/202306:38GlobeNewswire Inc.Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceNASDAQ:TILInstill Bio Inc
27/06/202306:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
15/06/202306:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
11/05/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
11/05/202321:00GlobeNewswire Inc.Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
29/04/202306:37Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:TILInstill Bio Inc
25/04/202306:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TILInstill Bio Inc
10/04/202323:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TILInstill Bio Inc
31/03/202322:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TILInstill Bio Inc
31/03/202322:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
31/03/202322:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TIL